News
04-21-2010, 09:11 AM
The New York Times writes about the frequent inaccuracy of a test to detect certain proteins in breast tumors, which determines whether the patient will get Herceptin, a potent breast cancer treatment. "Drugs aimed at disabling proteins that spur cancer are, many oncologists say, the future of cancer therapies. ...
More... (http://mnt.to/f/3By9)
More... (http://mnt.to/f/3By9)